(S)-2-Allyl-1-(3-hydroxy-3-methyl-2,3-dihydrofuro[3,2-b]pyridin-5-yl)-6-((4-(4-methylpiperazin-1-yl)phenyl)amino)-1,2-dihydro-3H-pyrazolo[3,4-d]pyrimidin-3-one

ID: ALA4861168

PubChem CID: 139482624

Max Phase: Preclinical

Molecular Formula: C27H30N8O3

Molecular Weight: 514.59

Molecule Type: Unknown

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  C=CCn1c(=O)c2cnc(Nc3ccc(N4CCN(C)CC4)cc3)nc2n1-c1ccc2c(n1)[C@@](C)(O)CO2

Standard InChI:  InChI=1S/C27H30N8O3/c1-4-11-34-25(36)20-16-28-26(29-18-5-7-19(8-6-18)33-14-12-32(3)13-15-33)31-24(20)35(34)22-10-9-21-23(30-22)27(2,37)17-38-21/h4-10,16,37H,1,11-15,17H2,2-3H3,(H,28,29,31)/t27-/m0/s1

Standard InChI Key:  PURQKJCVFGGRBZ-MHZLTWQESA-N

Molfile:  

 
     RDKit          2D

 38 43  0  0  0  0  0  0  0  0999 V2000
   11.2551  -15.0276    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.8447  -14.3228    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   10.4385  -15.0359    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.1566  -10.6500    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    1.1566  -11.4748    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.8691  -11.8853    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.5817  -11.4748    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    2.5817  -10.6500    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.8691  -10.2353    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.4404  -10.2375    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.2961  -11.8863    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.2917  -12.7154    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.0053  -13.1267    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.7219  -12.7174    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.7204  -11.8881    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.0063  -11.4763    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.4368  -13.1278    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    6.1478  -12.7176    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.8595  -13.1292    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    6.8546  -11.4793    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.1430  -11.8955    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    7.5747  -11.8939    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.5753  -12.7194    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.3609  -12.9727    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    8.8474  -12.3035    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    8.3598  -11.6352    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.6129  -10.8502    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    9.6724  -12.3028    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.0822  -11.5874    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.9072  -11.5867    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.6152  -13.7541    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.0646  -14.3685    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.3183  -15.1525    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.4193  -13.9221    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    9.6800  -14.7036    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.1287  -15.3225    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.5509  -16.0380    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   10.3608  -15.8615    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  3  2  1  1
  1  3  1  0
  4  5  1  0
  4  9  1  0
  5  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  1  0
  4 10  1  0
  7 11  1  0
 11 12  2  0
 12 13  1  0
 13 14  2  0
 14 15  1  0
 15 16  2  0
 16 11  1  0
 14 17  1  0
 17 18  1  0
 18 19  2  0
 19 23  1  0
 22 20  1  0
 20 21  2  0
 21 18  1  0
 22 23  2  0
 23 24  1  0
 24 25  1  0
 25 26  1  0
 26 22  1  0
 26 27  2  0
 25 28  1  0
 28 29  1  0
 29 30  2  0
 31 32  2  0
 32 33  1  0
 33 36  2  0
 35 34  2  0
 34 31  1  0
 24 31  1  0
 35 36  1  0
 36 37  1  0
 37 38  1  0
 38  3  1  0
  3 35  1  0
M  END

Alternative Forms

  1. Parent:

    ALA4861168

    ---

Associated Targets(Human)

WEE1 Tchem Serine/threonine-protein kinase WEE1 (1772 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
NCI-H23 (49055 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 514.59Molecular Weight (Monoisotopic): 514.2441AlogP: 2.26#Rotatable Bonds: 6
Polar Surface Area: 113.57Molecular Species: NEUTRALHBA: 11HBD: 2
#RO5 Violations: 2HBA (Lipinski): 11HBD (Lipinski): 2#RO5 Violations (Lipinski): 2
CX Acidic pKa: 12.68CX Basic pKa: 7.96CX LogP: 2.40CX LogD: 1.74
Aromatic Rings: 4Heavy Atoms: 38QED Weighted: 0.37Np Likeness Score: -0.91

References

1. Huang PQ, Boren BC, Hegde SG, Liu H, Unni AK, Abraham S, Hopkins CD, Paliwal S, Samatar AA, Li J, Bunker KD..  (2021)  Discovery of ZN-c3, a Highly Potent and Selective Wee1 Inhibitor Undergoing Evaluation in Clinical Trials for the Treatment of Cancer.,  64  (17.0): [PMID:34423975] [10.1021/acs.jmedchem.1c01121]

Source